Product Information
CLOBAZAM 2.5 MG/ML SUSPENSION is a generic product labeled by Chartwell RX LLC, priced at $0.1687 per ML under NDC 62135052741. Its NADAC has been published 198 times since Nov 9, 2022.
FDA first approved this application on Apr 24, 2020. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
Strength
2.5 mg/mL
Manufacturer
Chartwell RX LLCNDC
62135052741
Classification
Generic
Dosage Form
SUSPENSION
Route
ORAL
Effective Date
8/19/2026
Active Ingredients
CLOBAZAMApproval Type
Generic (ANDA)
FDA Application
ANDA213110FDA Approved
4/24/2020
TE Code
AB
On Market Since
4/24/2020
Pharmacological Classes
Price Statistics
The NADAC for CLOBAZAM 2.5 MG/ML SUSPENSION has been published 198 times since Nov 9, 2022, and over the history we have for it it has declined 61.2%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.1687 per ML |
|---|---|
| All-time high | $0.4349 (Nov 16, 2022) |
| All-time low | $0.1530 (May 20, 2026) |
| 52-week high | $0.1928 |
| 52-week low | $0.1530 |
| Median price | $0.2136 |
| Average price | $0.2222 |
| Largest weekly change | +32.4% (Aug 21, 2024) |
| Weeks tracked | 198 |
| Tracking since | Nov 9, 2022 |
Generic Alternatives
The matcher finds 5 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Frequently asked questions
What is the NADAC price of CLOBAZAM 2.5 MG/ML SUSPENSION?
The current National Average Drug Acquisition Cost (NADAC) for CLOBAZAM 2.5 MG/ML SUSPENSION, manufactured by Chartwell RX LLC, is $0.1687 per ML (NDC 62135052741), effective Aug 19, 2026.
How has the price of CLOBAZAM 2.5 MG/ML SUSPENSION changed over time?
Over the history we have for it, the NADAC for CLOBAZAM 2.5 MG/ML SUSPENSION has declined 61.2%. It has been tracked across 198 weekly CMS publications since Nov 9, 2022.
What are the highest and lowest recorded NADAC prices for CLOBAZAM 2.5 MG/ML SUSPENSION?
Since Nov 9, 2022, the NADAC for CLOBAZAM 2.5 MG/ML SUSPENSION has ranged from a low of $0.1530 (May 20, 2026) to a high of $0.4349 (Nov 16, 2022), with a median of $0.2136 per ML.
Are there cheaper alternatives to CLOBAZAM 2.5 MG/ML SUSPENSION?
5 manufacturers publish a NADAC-priced product with the same active ingredient and strength as CLOBAZAM 2.5 MG/ML SUSPENSION in a comparable dosage form, but none are currently priced below it.
Who manufactures CLOBAZAM 2.5 MG/ML SUSPENSION?
CLOBAZAM 2.5 MG/ML SUSPENSION (NDC 62135052741) is labeled by Chartwell RX LLC, and CMS classifies it as a generic product.